Patent 7425639 was granted and assigned to Smithkline Beecham Limited on September, 2008 by the United States Patent and Trademark Office.
An improved process for preparing arylethanoldiamines is described. Compounds of this type are known to be useful as agonists at a typical beta-adrenoceptors (also known as beta-3-adrenoceptors).